Immunological studies of mitoxantrone in primary progressive MS

Journal of Neuroimmunology
Clara M PelfreyRobert J Fox

Abstract

Mitoxantrone (MX) has demonstrated efficacy in multiple sclerosis (MS), but its immunologic mechanisms of action are poorly understood. Furthermore, no study has examined the immunological effects of MX in primary progressive MS (PPMS). This study investigated the immunological effects of MX therapy in PPMS patients. Lymphocyte phenotypes and chemokine receptor (CCR) expression were evaluated by flow cytometry on fresh PBMC from 20 PPMS patients enrolled in a placebo (PLC)-controlled trial of MX. Longitudinal data were collected at weeks 0, 12, 24, 36 and short-term data (pre-/post-infusion) were collected at weeks 0 and 36. CXCR3, CCR1, CCR2 and CCR5 on CD4 and CD8 T cells and CD14 monocytes were evaluated. MX therapy induced a significant increase in the proportion of CD8 T cells (CD45RO(-)) over 9 months. Expression of several CCR increased following MX treatment. Two of the eight MX-treated patients demonstrated dramatic upregulation (70-76%) of CCR2 on monocytes. These two patients were the only MX-treated patients to demonstrate active inflammation by magnetic resonance imaging (MRI). PLC patients did not show significant changes in CCR expression. MX therapy was not associated with selective loss of CD4, CD8 or CD14 cell...Continue Reading

References

Jan 1, 1992·European Archives of Psychiatry and Clinical Neuroscience·E MauchH Laufen
Jan 1, 1986·International Journal of Immunopharmacology·B S WangF E Durr
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Jun 29, 2004·Multiple Sclerosis : Clinical and Laboratory Research·Olaf StüveScott S Zamvil
Dec 21, 2004·Clinical and Experimental Immunology·A ChanR Gold
Sep 21, 2005·Journal of Neuroimmunology·Oliver NeuhausHans-Peter Hartung

❮ Previous
Next ❯

Citations

Aug 14, 2012·Acta Neurologica Scandinavica·A Jamroz-WisniewskaH Bartosik-Psujek
Apr 27, 2011·Immunopharmacology and Immunotoxicology·Jun-Min LiYuan-Wu Mei
Nov 16, 2012·Nature Reviews. Cancer·Dmitri V KryskoPeter Vandenabeele
Jan 5, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tania Løve AaesPeter Vandenabeele
Aug 1, 2019·Biomedicines·Gabrielle Macaron, Daniel Ontaneda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis